-+ 0.00%
-+ 0.00%
-+ 0.00%
*Aethlon Medical: Phase 1a Study of NOR-101 Expected to Begin 1Q 2027, With Interim Data Expected by Mid-2027 and Phase 1b and Phase 2b Topline Data Expected in 2028 >AEMD
Share

Please log in to view news

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending